Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
clinical trials
life sciences
national blog main
akouos
andrew berens
astellas pharmaceuticals
avapritinib
biotech
blueprint medicines
california institute for biomedical research
cancer
deals
decibel therapeutics
deciphera pharmaceuticals
fda
frequency therapeutics
gastrointestinal stromal tumor
gist
gleevec
harvard university
hearing loss
imatinib
investing
jeffrey karp
multiple sclerosis
perceptive life sciences
regenerative medicine
regorafenib
ripretinib
robert langer
san francisco blog main
sensorineural hearing loss
steve hoerter
stivarga
sunitinib
sutent
svb leerink
taiwania capital management
What
drug
fda
2
×
plans
2
×
affects
americans
announced
approval
approved
blueprint
cancer
chasing
date
deadly
deciphera
developing
filing
forms
frequency
gi
hearing
ipo
loss
medicine
medicines
meds
millions
morning
pharamceuticals
regenerative
seek
therapeutics
treat
treats
tumor
type
Language
unset
Current search:
boston
×
fda
×
plans
×
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
